Canine Recombinant Adenovirus Vector Induces an Immunogenicity-Related Gene Expression Profile in Skin-Migrated CD11b+ -Type DCs

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Contreras, Vanessa ^a   Urien, Céline ^a   Jouneau, Luc ^a   Bourge, Mickael ^b   Bouet Cararo, Coraline ^c   Bonneau, Michel ^d   Zientara, Stephan ^c   Klonjkowski, Bernard ^c   Schwartz Cornil, Isabelle ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b CNRS   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^d CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD103 ANTIGEN; CD11B ANTIGEN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL AGGREGATION; CELL MIGRATION; CELL SUBPOPULATION; CELL TRANSPORT; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; DOG; DRUG SAFETY; FEMALE; GENE EXPRESSION PROFILING; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATION; LYMPH VESSEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; SEROTYPE; SHEEP; SKIN CELL; TRANSGENE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TYPING;

ADENOVIRUSES, CANINE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD11B; CELL MOVEMENT; DENDRITIC CELLS; DNA, RECOMBINANT; DOGS; FEMALE; GENETIC VECTORS; HUMANS; INTEGRIN ALPHA CHAINS; SHEEP; SKIN; TRANSCRIPTOME; VACCINATION;

ADENOVIRIDAE; CANINE ADENOVIRUS; CANIS FAMILIARIS; HUMAN ADENOVIRUS; OVIS ARIES;

EID: 84871600279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052513     Document Type: Article

References (42)

1. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, et al. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10: 116-125.
2. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, et al. (2011) Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 12: 786-795.
3. Top S, Foulon E, Pignolet B, Deplanche M, Caubet C, et al. (2011) Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector. J Virol 85: 12982-12994.
4. Combadiere B, Mahe B, (2008) Particle-based vaccines for transcutaneous vaccination. Comp Immunol Microbiol Infect Dis 31: 293-315.
5. Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, et al. (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25: 1159-1164.
6. de Gruijl TD, Ophorst OJ, Goudsmit J, Verhaagh S, Lougheed SM, et al. (2006) Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells. J Immunol 177: 2208-2215.
7. Epardaud M, Bonneau M, Payot F, Cordier C, Megret J, et al. (2004) Enrichment for a CD26hi SIRP- subset in lymph dendritic cells from the upper aero-digestive tract. J Leukoc Biol 76: 553-561.
8. Marquet F, Bonneau M, Pascale F, Urien C, Kang C, et al. (2011) Characterization of dendritic cells subpopulations in skin and afferent lymph in the Swine model. PLoS One 6: e16320.
9. Contreras V, Urien C, Guiton R, Alexandre Y, Vu Manh TP, et al. (2010) Existence of CD8{alpha}-Like Dendritic Cells with a Conserved Functional Specialization and a Common Molecular Signature in Distant Mammalian Species. J Immunol 185: 3313-3325.
10. Kremer EJ, (2004) CAR chasing: canine adenovirus vectors-all bite and no bark? J Gene Med 6Suppl 1: S139-151.
11. Perreau M, Kremer EJ, (2006) The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy. Mol Biotechnol 34: 247-256.
12. Benlahrech A, Harris J, Meiser A, Papagatsias T, Hornig J, et al. (2009) Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proc Natl Acad Sci U S A 106: 19940-19945.
13. Lindsay RW, Darrah PA, Quinn KM, Wille-Reece U, Mattei LM, et al. (2010) CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J Immunol 185: 1513-1521.
14. Keriel A, Rene C, Galer C, Zabner J, Kremer EJ, (2006) Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors. J Virol 80: 1487-1496.
15. Bru T, Salinas S, Kremer EJ, (2010) An update on canine adenovirus type 2 and its vectors. Viruses 2: 2134-2153.
16. Yuan ZG, Li XM, Mahmmod YS, Wang XH, Xu HJ, et al. (2009) A single immunization with a recombinant canine adenovirus type 2 expressing the seoul virus Gn glycoprotein confers protective immunity against seoul virus in mice. Vaccine 27: 5247-5251.
17. Hu R, Zhang S, Fooks AR, Yuan H, Liu Y, et al. (2006) Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes and infection/ Institut Pasteur 8: 1090-1097.
18. Hu RL, Liu Y, Zhang SF, Zhang F, Fooks AR, (2007) Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 25: 5301-5307.
19. Liu Y, Zhang S, Ma G, Zhang F, Hu R, (2008) Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine. Vaccine 26: 5368-5372.
20. Bouet-Cararo C, Contreras V, Fournier A, Jallet C, Guibert JM, et al. (2011) Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep. Vaccine 29: 1304-1310.
21. Schwartz-Cornil I, Epardaud M, Bonneau M, (2006) Cervical duct cannulation in sheep for collection of afferent lymph dendritic cells from head tissues. Nature protocols 1: 874.
22. Pascale F, Contreras V, Bonneau M, Courbet A, Chilmonczyk S, et al. (2008) Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol 180: 5963-5972.
23. Miller G, Lahrs S, Shah AB, DeMatteo RP, (2003) Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus. Cancer Immunol Immunother 52: 347-358.
24. Perreau M, Mennechet F, Serratrice N, Glasgow JN, Curiel DT, et al. (2007) Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy. J Virol 81: 3272-3284.
25. Cubillos-Zapata C, Guzman E, Turner A, Gilbert SC, Prentice H, et al. (2011) Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predicts enhanced immunogenicity in vivo. J Virol 85: 9385-9394.
26. Smyth G (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology.
27. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
28. Casel P, Moreews F, Lagarrigue S, Klopp C, (2009) sigReannot: an oligo-set re-annotation pipeline based on similarities with the Ensembl transcripts and Unigene clusters. BMC proceedings 3Suppl 4: S3.
29. Hartman ZC, Black EP, Amalfitano A, (2007) Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology 358: 357-372.
30. Kushwah R, Hu J, (2011) Complexity of dendritic cell subsets and their function in the host immune system. Immunology 133: 409-419.
31. Adams WC, Bond E, Havenga MJ, Holterman L, Goudsmit J, et al. (2009) Adenovirus Serotype 5 Infects Human Dendritic Cells via a CAR-Independent Receptor Pathway Mediated by Lactoferrin and DC-SIGN. J Gen Virol 90: 1600-1610.
32. Verhaagh S, de Jong E, Goudsmit J, Lecollinet S, Gillissen G, et al. (2006) Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors. J Gen Virol 87: 255-265.
33. Morelli AE, Larregina AT, Ganster RW, Zahorchak AF, Plowey JM, et al. (2000) Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. Journal of virology 74: 9617-9628.
34. Cheng C, Gall JG, Kong WP, Sheets RL, Gomez PL, et al. (2007) Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells. PLoS pathogens 3: e25.
35. Zhang Z, Yuan B, Bao M, Lu N, Kim T, et al. (2011) The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 12: 959-965.
36. Henning P, Gustafsson T, Flach CF, Hua YJ, Strombeck A, et al. (2011) The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells. European journal of immunology 41: 2185-2196.
37. Hangalapura BN, Oosterhoff D, Gupta T, de Groot J, Wijnands PG, et al. (2011) Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine. Vaccine 29: 2313-2321.
38. Soudais C, Boutin S, Hong SS, Chillon M, Danos O, et al. (2000) Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. Journal of virology 74: 10639-10649.
39. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, et al. (2003) Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33: 827-833.
40. Nalubamba KS, Gossner AG, Dalziel RG, Hopkins J, (2007) Differential expression of pattern recognition receptors in sheep tissues and leukocyte subsets. Vet Immunol Immunopathol 118: 252-262.
41. Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M, et al. (2010) Quantitative Proteomics Reveals Subset-Specific Viral Recognition in Dendritic Cells. Immunity 32: 279-289.
42. Buschow SI, Figdor CG, (2010) Dendritic cell subsets digested: RNA sensing makes the difference! Immunity. 32: 149-151.